Time course of glatiramer acetate efficacy in patients with RRMS in the GALA study

OBJECTIVE: To determine the time to efficacy onset of glatiramer acetate (GA) 40 mg/mL 3-times-weekly formulation (GA40). METHODS: This post hoc analysis of data from the 1-year, double-blind, placebo-controlled phase of the Glatiramer Acetate Low-Frequency Administration study (NCT01067521) of GA40...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Mat D., Ashtamker, Natalia, Steinerman, Joshua R., Knappertz, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299631/
https://www.ncbi.nlm.nih.gov/pubmed/28210662
http://dx.doi.org/10.1212/NXI.0000000000000327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299631/
https://www.ncbi.nlm.nih.gov/pubmed/28210662
http://dx.doi.org/10.1212/NXI.0000000000000327

Ejemplares similares